Evaluation of Physostigmine Salicylate Using a High Concentration of Liver S-9 Fraction in the Ames Test for Mutagenicity
Abstract
The mutagenic potential of PHYSOSTIGMINE SALICYLATE was assessed in the Ames Test both in the presence and absence of a 10% liver S-9 activation mixture. The test compound was not mutagenic under the conditions of this test. Keywords: Physostigmine salicylate; Ames test; Genetic toxicology; Mutagenicity.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 1989
- Accession Number
- ADA211276
Entities
People
- Don W. Korte Jr.
- Suzanne E. Sebastian
Organizations
- Letterman Army Hospital